Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences

NEXT STORY
Global Point of Care/Rapid Diagnostics Market (2020 to 2025) – Increasing Provider Awareness About Novel Technologies Presents Opportunities
PREV STORY
Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Publishes New Data on FR104, CD28-Antagonist Immunotherapy

FR104 shows immune tolerance superiority over CTLA4-Ig in humanized skin transplant model FR104 efficacious ...

author_avatar
NASDAQ Market News

Point-of-Care (POC) Diagnostics World Market Study, 2019-2025 – Smart Devices Equipped with Mobile Healthcare is Expected to Revolutionize Personalized Healthcare Monitoring & Management

author_avatar
NASDAQ Market News

Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease

author_avatar
NASDAQ Market News